Article
A targeted next-generation sequencing in the molecular risk stratification of adult acute myeloid leukemia: implications for clinical practice.
Cancer medicine - 1 Feb 2017
Lin Po-Han, Li Huei-Ying, Fan Sheng-Chih, Yuan Tzu-Hang, Chen Ming, Hsu Yu-Hua, Yang Yu-Hsuan, Li Long-Yuan, Yeh Su-Peng, Bai Li-Yuan, Liao Yu-Min, Lin Chen-Yuan, Hsieh Ching-Yun, Lin Ching-Chan, Lin Che-Hung, Lien Ming-Yu, Chen Tzu-Ting, Ni Yen-Hsuan, Chiu Chang-Fang
Abstract excerpt
Conventional cytogenetics can categorize patients with acute myeloid leukemia (AML) into favorable, intermediate, and unfavorable-risk groups; however, patients with intermediate-risk cytogenetics represent the major population with variable outcomes. Because molecular profiling can assist with AML prognosis and next-generation sequencing allows simultaneous sequencing of many target genes, we analyzed 260 genes...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
